La cadena de opciones muestra datos clave de las opciones de acciones de Sidus Space a varios precios de ejercicio y fechas de vencimiento. Los operadores utilizan esta información para analizar posibles operaciones y evaluar el sentimiento del mercado para Sidus Space..

Sidus Space (NASDAQ:SIDU) Bolsa, Cadena de Opciones

Sidus Space

Sidus Space Inc is a Space and Defense as-a-Service company focused on providing complex space hardware, satellite/spacecraft design, manufacture, launch, and data solutions for both government and commercial in-space missions for all destinations through the solar system. This includes a Space-based infrastructure of multi-mission satellites with hyperspectral, multi-spectral, and other sensors to provide monitoring services and solutions to multiple sectors and industries. The company supports Commercial Space, Aerospace, Defense, Underwater Marine, and other commercial and government customers.

Sidus Space Inc

SIDUS HEROES

Goldman Sachs analyst Mike Harris maintains Cleveland-Cliffs (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CLF#NYSE">CLF</a>) with a Buy and lowers the price target from $13 to $11.25.

News

Price Target

Analyst Ratings

Goldman Sachs Maintains Buy on Cleveland-Cliffs, Lowers Price Target to $11.25

In the current session, the stock is trading at $31.47, after a 1.16% increase. Over the past month, Enterprise Prods Partners Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/EPD#NYSE">EPD</a>) stock increased by 2.08%, and in the past year, by 9.06%. With performance like this, long-term shareholders are optimistic but others are more likely to look into the price-to-earnings ratio to see if the stock might be overvalued.

<img src="https://www.benzinga.com/files/images/story/2025/1747069257_0.png" alt="Past Year Chart" />

<h3>Enterprise Prods Partners P/E Compared to Competitors</h3>
The P/E ratio is used by long-term shareholders to assess the company's market performance against aggregate market data, historical earnings, and the industry at large. A lower P/E could indicate that shareholders do not expect the stock to perform better in the future or it could mean that the company is undervalued. 
Compared to the aggregate P/E ratio of the 19.96 in the Oil, Gas &amp; Consumable Fuels industry, Enterprise Prods Partners Inc. has a lower P/E ratio of 11.65. Shareholders might be inclined to think that the stock might perform worse than it's industry peers. It's also possible that the stock is undervalued. 

<img src="https://www.benzinga.com/files/images/story/2025/1747069257_1.png" alt="Guage" />

In summary, while the price-to-earnings ratio is a valuable tool for investors to evaluate a company's market performance, it should be used with caution. A low P/E ratio can be an indication of undervaluation, but it can also suggest weak growth prospects or financial instability. Moreover, the P/E ratio is just one of many metrics that investors should consider when making investment decisions, and it should be evaluated alongside other financial ratios, industry trends, and qualitative factors. By taking a comprehensive approach to analyzing a company's financial health, investors can make well-informed decisions that are more likely to lead to successful outcomes.

Intraday Update

Markets

P/E Ratio Insights for Enterprise Prods Partners

Wells Fargo analyst Richard Garchitorena maintains CF Industries Holdings (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CF#NYSE">CF</a>) with a Overweight and raises the price target from $96 to $98.

Wells Fargo Maintains Overweight on CF Industries Holdings, Raises Price Target to $98

Trading Ideas

AMZN

CNBC Halftime Report Final Trades: Citigroup, Truist Financial, Amazon

Estee Lauder Cos's (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/EL#NYSE">EL</a>) short percent of float has risen 8.15% since its last report. The company recently reported that it has 8.95 million shares sold short, which is 3.85% of all regular shares that are available for trading. Based on its trading volume, it would take traders 2.43 days to cover their short positions on average.
<h3>Why Short Interest Matters</h3>
Short interest is the number of shares that have been sold short but have not yet been covered or closed out. <a href="https://www.benzinga.com/money/how-to-short-a-stock?adType=benzinga-insights&amp;ad=short-interest&amp;campaign=wallstreetadvantage">Short selling</a> is when a trader sells shares of a company they do not own, with the hope that the price will fall. Traders make money from short selling if the price of the stock falls and they lose if it rises.
Short interest is important to track because it can act as an indicator of market sentiment towards a particular stock. An increase in short interest can signal that investors have become more bearish, while a decrease in short interest can signal they have become more bullish.
See Also: <a href="https://www.benzinga.com/short-interest?adType=benzinga-insights&amp;ad=short-interest&amp;campaign=wallstreetadvantage">List of the most shorted stocks</a>
<h3>Estee Lauder Cos Short Interest Graph (3 Months)</h3>
<img src="https://www.benzinga.com/files/images/story/2025/1747069233_0.png" alt="short_fig" />
As you can see from the chart above the percentage of shares that are sold short for Estee Lauder Cos has grown since its last report. This does not mean that the stock is going to fall in the near-term but traders should be aware that more shares are being shorted.
<h3>Comparing Estee Lauder Cos's Short Interest Against Its Peers</h3>
Peer comparison is a popular technique amongst analysts and investors for gauging how well a company is performing. A company's peer is another company that has similar characteristics to it, such as industry, size, age, and financial structure. You can find a company's peer group by reading its 10-K, proxy filing, or by doing your own similarity analysis.
According to <a href="https://www.benzinga.com/pro/">Benzinga Pro</a>, Estee Lauder Cos's peer group average for short interest as a percentage of float is 5.85%, which means the company has less short interest than most of its peers.
Did you know that increasing short interest can actually be bullish for a stock? <a href="https://www.benzinga.com/money/how-to-make-money-on-a-short-squeeze?adType=benzinga-insights&amp;ad=short-interest&amp;campaign=wallstreetadvantage">This post by Benzinga Money explains how you can profit from it.</a>
This article was generated by Benzinga's automated content engine and was reviewed by an editor.

Short Sellers

Short Ideas

How Do Investors Really Feel About Estee Lauder Cos?

Avient's (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/AVNT#NYSE">AVNT</a>) short percent of float has fallen 3.77% since its last report. The company recently reported that it has 1.77 million shares sold short, which is 2.55% of all regular shares that are available for trading. Based on its trading volume, it would take traders 3.52 days to cover their short positions on average.
<h3>Why Short Interest Matters</h3>
Short interest is the number of shares that have been sold short but have not yet been covered or closed out. <a href="https://www.benzinga.com/money/how-to-short-a-stock?adType=benzinga-insights&amp;ad=short-interest&amp;campaign=wallstreetadvantage">Short selling</a> is when a trader sells shares of a company they do not own, with the hope that the price will fall. Traders make money from short selling if the price of the stock falls and they lose if it rises.
Short interest is important to track because it can act as an indicator of market sentiment towards a particular stock. An increase in short interest can signal that investors have become more bearish, while a decrease in short interest can signal they have become more bullish.
See Also: <a href="https://www.benzinga.com/short-interest?adType=benzinga-insights&amp;ad=short-interest&amp;campaign=wallstreetadvantage">List of the most shorted stocks</a>
<h3>Avient Short Interest Graph (3 Months)</h3>
<img src="https://www.benzinga.com/files/images/story/2025/1747069227_0.png" alt="short_fig" />
As you can see from the chart above the percentage of shares that are sold short for Avient has declined since its last report. This does not mean that the stock is going to rise in the near-term but traders should be aware that less shares are being shorted.
<h3>Comparing Avient's Short Interest Against Its Peers</h3>
Peer comparison is a popular technique amongst analysts and investors for gauging how well a company is performing. A company's peer is another company that has similar characteristics to it, such as industry, size, age, and financial structure. You can find a company's peer group by reading its 10-K, proxy filing, or by doing your own similarity analysis.
According to <a href="https://www.benzinga.com/pro/">Benzinga Pro</a>, Avient's peer group average for short interest as a percentage of float is 4.41%, which means the company has less short interest than most of its peers.
Did you know that increasing short interest can actually be bullish for a stock? <a href="https://www.benzinga.com/money/how-to-make-money-on-a-short-squeeze?adType=benzinga-insights&amp;ad=short-interest&amp;campaign=wallstreetadvantage">This post by Benzinga Money explains how you can profit from it.</a>
This article was generated by Benzinga's automated content engine and was reviewed by an editor.

AVNT

Is Avient Gaining or Losing Market Support?

CSX's (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CSX#NYSE">CSX</a>) short percent of float has fallen 7.32% since its last report. The company recently reported that it has 28.55 million shares sold short, which is 1.52% of all regular shares that are available for trading. Based on its trading volume, it would take traders 1.7 days to cover their short positions on average.
<h3>Why Short Interest Matters</h3>
Short interest is the number of shares that have been sold short but have not yet been covered or closed out. <a href="https://www.benzinga.com/money/how-to-short-a-stock?adType=benzinga-insights&amp;ad=short-interest&amp;campaign=wallstreetadvantage">Short selling</a> is when a trader sells shares of a company they do not own, with the hope that the price will fall. Traders make money from short selling if the price of the stock falls and they lose if it rises.
Short interest is important to track because it can act as an indicator of market sentiment towards a particular stock. An increase in short interest can signal that investors have become more bearish, while a decrease in short interest can signal they have become more bullish.
See Also: <a href="https://www.benzinga.com/short-interest?adType=benzinga-insights&amp;ad=short-interest&amp;campaign=wallstreetadvantage">List of the most shorted stocks</a>
<h3>CSX Short Interest Graph (3 Months)</h3>
<img src="https://www.benzinga.com/files/images/story/2025/1747069221_0.png" alt="short_fig" />
As you can see from the chart above the percentage of shares that are sold short for CSX has declined since its last report. This does not mean that the stock is going to rise in the near-term but traders should be aware that less shares are being shorted.
<h3>Comparing CSX's Short Interest Against Its Peers</h3>
Peer comparison is a popular technique amongst analysts and investors for gauging how well a company is performing. A company's peer is another company that has similar characteristics to it, such as industry, size, age, and financial structure. You can find a company's peer group by reading its 10-K, proxy filing, or by doing your own similarity analysis.
According to <a href="https://www.benzinga.com/pro/">Benzinga Pro</a>, CSX's peer group average for short interest as a percentage of float is 9.37%, which means the company has less short interest than most of its peers.
Did you know that increasing short interest can actually be bullish for a stock? <a href="https://www.benzinga.com/money/how-to-make-money-on-a-short-squeeze?adType=benzinga-insights&amp;ad=short-interest&amp;campaign=wallstreetadvantage">This post by Benzinga Money explains how you can profit from it.</a>
This article was generated by Benzinga's automated content engine and was reviewed by an editor.

Is the Market Bullish or Bearish on CSX?

Goldman Sachs analyst Michael Ng maintains Blend Labs (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BLND#NYSE">BLND</a>) with a Buy and lowers the price target from $5.6 to $4.8.

BLND

Goldman Sachs Maintains Buy on Blend Labs, Lowers Price Target to $4.8

<a href="https://www.benzinga.com/markets/cryptocurrency/25/05/45333766/ethereum-dogecoin-and-other-altcoins-may-erase-4-years-suffering-in-just-months-says-michael-van-de-poppe-amid-historic-bullish-divergence">Altcoins are surging</a> as Bitcoin dominance pulls back, suggesting a renewed flow of capital into Ethereum and the broader altcoin market. Celebrity interest is also heating up, adding fuel to the narrative.
What Happened: Six-time NBA champion Scottie Pippen joined the crypto conversation with a <a href="https://x.com/ScottiePippen/status/1921317743774593468">post</a> on X, declaring "altcoin season is here." 
He highlighted his focus on Ethereum (CRYPTO: <a class="ticker" href="https://www.benzinga.com/quote/eth/usd">ETH</a>), XRP (CRYPTO: <a class="ticker" href="https://www.benzinga.com/quote/xrp/usd">XRP</a>), Solana (CRYPTO: <a class="ticker" href="https://www.benzinga.com/quote/sol/usd">SOL</a>), Cardano (CRYPTO: <a class="ticker" href="https://www.benzinga.com/quote/ada/usd">ADA</a>), Dogecoin (CRYPTO: <a class="ticker" href="https://www.benzinga.com/quote/doge/usd">DOGE</a>), Shiba Inu (CRYPTO: <a class="ticker" href="https://www.benzinga.com/quote/shib/usd">SHIB</a>) and Mog Coin (CRYPTO: <a class="ticker" href="https://www.benzinga.com/quote/">MOG</a>) and asked Crypto Twitter what else they&#8217;re bullish on.
Pippen's tweet came just as Bitcoin dominance slipped from 64% to 61.5%, marking a 0.8% decline in a single day. 
According to DamiDefi, this drop <a href="https://x.com/DamiDefi/status/1921928635637969101">reflects</a> a rotation of liquidity toward altcoins, especially Ethereum and altcoins.
<figure class="wp-block-embed is-type-rich is-provider-twitter wp-block-embed-twitter"> 
<div class="wp-block-embed__wrapper">
<blockquote class="twitter-tweet" data-width="500" data-dnt="true"><a href="https://twitter.com/search?q=%24BTC&amp;src=ctag&amp;ref_src=twsrc%5Etfw">$BTC</a> dominance goes crashing as liquidity flows into <a href="https://twitter.com/search?q=%24ETH&amp;src=ctag&amp;ref_src=twsrc%5Etfw">$ETH</a> and altcoins <a href="https://t.co/T3xt5bab41">pic.twitter.com/T3xt5bab41</a>
&mdash; Dami-Defi (@DamiDefi) <a href="https://twitter.com/DamiDefi/status/1921928635637969101?ref_src=twsrc%5Etfw">May 12, 2025</a></blockquote>
<script async src="https://platform.twitter.com/widgets.js" charset="utf-8"></script></div>
</figure>
Echoing this sentiment, analyst Michael van de Poppe <a href="https://x.com/CryptoMichNL/status/1921920545811259552">pointed</a> to a bearish divergence on the Bitcoin dominance chart, calling it a sign of the altcoin bear market ending. 
Another trader, Niels, <a href="https://x.com/Web3Niels/status/1921913680553238959">sees</a> a BTC dominance drop below 63% pushed altcoins "massively outperforming." 
He pointed out that Ethereum is up 45%, Solana spiked 30%, while many others surged 80%-100%. He believes a macro risk-on environment is reinforcing the altcoin breakout, with momentum clearly shifting in their favor.
Also Read: <a href="https://www.benzinga.com/markets/cryptocurrency/25/05/45351445/xrp-skyrockets-10-what-is-going-on">XRP Skyrockets 10%: What Is Going On?</a>
Why It Matters: As altcoins gain strength, traders are adjusting their strategies. 
Analyst Miles Deutscher said in his latest <a href="https://www.youtube.com/watch?v=5NbIK4uCu6M">podcast</a> that the trend is clear: &#8220;Long strong alts on pullbacks until the trend has shifted, whilst they&#8217;re still above key high time frame levels.&#8221;
He pegs Bitcoin at $100,000 and Ethereum at $2,000 as crucial levels. 
As long as they remain above these thresholds, Deutscher stays bullish on the further upside. 
Still, he cautions against confusing short-term opportunities with long-term investments:
"I think it&#8217;s a big mistake right now to start loading into or buying or FOMOing into long-term spot just because the market&#8217;s moved," he cautioned, suggesting traders should "treat these shorter-term entries as trades" while maintaining separate strategies for long-term holdings.
Read Next:
<ul class="wp-block-list">
<li><a href="https://www.benzinga.com/markets/cryptocurrency/25/05/45348013/dogecoin-jumps-4-can-doge-hit-1-soon">Dogecoin Jumps 4%: Can DOGE Hit $1 Soon?</a></li>
</ul>
Image: Shutterstock

Coverage of Bitcoin, Etherum, Ripple and all the latest digital currencies.

Cryptocurrency

$ADA

$DOGE

$ETH

$MOG

$SHIB

$SOL

$XRP

Scottie Pippen Declares 'Altcoin Season' As Ethereum, XRP, Dogecoin, Shiba Inu Rally

For many Americans approaching retirement, the idea of claiming Social Security benefits at age 62 is tempting. It offers early access to a steady stream of income and can bring a sense of security during uncertain times. But financial expert Suze Orman says this move is often a costly mistake.
In a recent episode of her "<a href="https://omny.fm/shows/suze-ormans-women-and-money/suze-school-the-actions-you-need-to-take-now-with-your-money">Women &amp; Money</a>" podcast, Orman pulled no punches: "Taking your Social Security payments at 62 is wrong." Here's what she means — and why it may be worth waiting.
Don't Miss:
<ul class="wp-block-list">
<li>‘Scrolling To UBI' — Deloitte's #1 fastest-growing software company allows users to earn money on their phones. <a href="https://www.benzinga.com/money/mode-mobile-2">You can invest today for just $0.30/share with a $1000 minimum.</a></li>
<li>Maker of the $60,000 foldable home has 3 factory buildings, 600+ houses built, and big plans to solve housing —<a href="https://www.benzinga.com/money/boxabl"> this is your last chance to become an investor for $0.80 per share.</a></li>
</ul>
<h2 class="wp-block-heading">Claiming Early Comes at a Cost</h2>
While age 62 is the earliest point you can claim <a href="https://www.benzinga.com/personal-finance/25/04/45110258/the-2026-social-security-cola-could-be-the-biggest-in-years-but-inflation-could-still-outpace-your-benefits">Social Security benefits</a>, doing so permanently reduces your monthly payments. Orman reminds listeners that 62 is usually five years before full retirement age, which is between 66 and 67, depending on your birth year.
That early start results in up to a 30% reduction in your monthly benefit — for life. "You are taking a serious hit on it, but that makes you feel more secure," she said. While the idea of receiving money sooner may feel like a safe move, Orman believes many people are letting fear dictate their financial decisions.&nbsp;
<h2 class="wp-block-heading">Who Benefits When You Claim Early?</h2>
Orman argues that <a href="https://www.benzinga.com/25/05/45265236/80000-more-americans-filed-for-social-security-in-march-compared-with-last-year-whats-driving-this-surge">claiming early</a> often benefits the system more than the retiree. "The more of you that take it at 62, the less they have to pay you later on," she said. In other words, starting benefits early helps save money for Social Security, but may cost retirees tens of thousands of dollars over time.
Trending: Many are using retirement income calculators to check if they&#8217;re on pace —<a href="https://www.benzinga.com/money/how-do-i-calculate-my-retirement-income-adv"> here&#8217;s a breakdown on what&#8217;s behind this formula.</a>
With concerns about the future of Social Security funding and the state of staffing with offices being shut down, some Americans are rushing to claim benefits out of fear the program will run out or face serious disruptions. But Orman says this is the wrong approach.&nbsp;
"That doesn't mean Social Security is going to collapse," she stated.
<h2 class="wp-block-heading">When Taking Benefits Early Might Make Sense</h2>
Orman acknowledges that there are valid reasons to claim Social Security at 62. If you&#8217;re in poor health or have a terminal illness, taking benefits early may be practical. But in most cases, she says waiting is the better option — especially for married couples.
"Most of the time it absolutely makes no sense at all taking Social Security before your full retirement age," she said. "And I will still say in most cases if you can wait till you are 70 and it makes sense to do so…especially if you are married."
See Also: <a href="https://www.benzinga.com/money/suze-orman-retirement-bucket">&#8216;Which Bucket Do I Draw From First?&#8217; Suze Orman Explains To 67-Year-Old The Best Order For Tapping Into Her Retirement Accounts</a>&nbsp;
<h2 class="wp-block-heading">Take Time To Create a Plan</h2>
Rather than making a quick decision based on fear or uncertainty, Orman urges listeners to plan carefully. The key, she says, is figuring out both the best and worst times for you to claim benefits — not just emotionally, but financially.
"Take action with your Social Security," Orman said. That means understanding how timing impacts your <a href="https://www.benzinga.com/personal-finance/25/03/44424162/its-a-really-really-bad-idea-suze-orman-warns-58-year-old-against-using-a-401k-to-buy-a-lifetime">lifetime income</a> and considering your health, marital status, and overall retirement plan.
Bottom line: If you're nearing retirement, it may be worth thinking twice before taking Social Security at 62. A little patience — and planning — can pay off in the long run.
Read Next:
<ul class="wp-block-list">
<li><a href="https://www.benzinga.com/money/gbr-savings-by-age">If You're Age 35, 50, or 60: Here&#8217;s How Much You Should Have Saved Vs. Invested By Now</a></li>
<li>Nancy Pelosi Invested $5 Million In An AI Company Last Year — <a href="https://www.benzinga.com/money/elf-labs">Here's How You Can Invest In Multiple Pre-IPO AI Startups With Just $1,000.</a></li>
</ul>
Image: Shutterstock

Personal Finance

Suze Orman: 'Taking your Social Security Payments At 62 Is Wrong' - Here's Why

WIIM

FOXA

Fox shares are trading higher after the company reported Q3 financial results and beat its adjusted EPS and revenue estimate.

ABNB

EXPE

Melco Resorts & Entertainment Limited - American Depositary Shares

MLCO

MMYT

NCLH

PLAY

ULCC

WYNN

Shares of travel and leisure stocks are trading higher after the US and China agreed to a temporary reduction in most tariffs on each other's goods. This could reduce economic uncertainty that has been clouding travel and spending outlook.

Wells Fargo analyst Richard Garchitorena maintains Mosaic (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MOS#NYSE">MOS</a>) with a Equal-Weight and raises the price target from $28 to $35.

Wells Fargo Maintains Equal-Weight on Mosaic, Raises Price Target to $35

Wells Fargo analyst Richard Garchitorena maintains Nutrien (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/NTR#NYSE">NTR</a>) with a Equal-Weight and raises the price target from $56 to $59.

Wells Fargo Maintains Equal-Weight on Nutrien, Raises Price Target to $59

Intel Corporation (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/INTC#NASDAQ">INTC</a>) shares are trading higher Monday after the U.S. and China agreed to a temporary reduction in most tariffs on <a href="https://www.benzinga.com//node/45352452">each other&#8217;s goods</a>.
What To Know: According to <a href="https://www.npr.org/2025/05/12/nx-s1-5395027/us-china-tariffs-deal-trade-war-beijing-washington">NPR</a>, the deal will drop U.S. tariffs on Chinese goods from 145% to 30% and Chinese duties on U.S. imports from 125% to 10% for a three-month period.
On the U.S. side, the talks were led by Trade Representative Jamieson Greer and Treasury Secretary Scott Bessent, while Vice Premier He Lifeng led the discussions for China.
Bessent said at a press conference that, &#8220;We concluded that we have shared interests, and we both have an interest in balanced trade.&#8221; In addition, Greer stated that there is a &#8220;positive path forward&#8221; on the two countries working to combat fentanyl smuggling.
The updated U.S. tariff levels include a base 10% tariff on all imports, along with an additional 20% tariff introduced earlier this year by President Donald Trump in response to allegations that China is producing chemicals linked to fentanyl.
The U.S. is reportedly now in talks with China to increase its purchases of American goods.
Intel stock may be trading higher as a reduction in tariffs could alleviate some supply chain concerns and improve macro sentiment as well as demand visibility. Other chip stocks, including Advanced Micro Devices, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AMD#NASDAQ">AMD</a>), are also trading higher following the news.
Notably, sales from China accounted for about 30% of Intel&#8217;s <a href="https://seekingalpha.com/news/4432161-intel-faces-potentially-significant-impact-from-chinas-import-tariffs-wells-fargo">revenue in 2024.</a>
See Also: <a href="https://www.benzinga.com/25/05/45353407/ramit-sethi-identifies-two-key-traits-of-people-who-are-growing-their-finances-you-think-in-percentages-and-strategy">Ramit Sethi Identifies Two Key Traits Of People Who Are Growing Their Finances: &#8216;You Think In Percentages And Strategy&#8217;</a>
INTC Price Action: At the time of writing, Intel shares are trading 3.91% higher at $22.25, according to data from <a href="https://www.benzinga.com/pro/login">Benzinga Pro</a>.
Image: via Shutterstock

Movers

INTC

Intel Stock Is Rising Monday: What's Going On?

Goldman Sachs analyst Gabriela Borges maintains AvePoint (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AVPT#NASDAQ">AVPT</a>) with a Neutral and raises the price target from $15 to $17.

AVPT

Goldman Sachs Maintains Neutral on AvePoint, Raises Price Target to $17

Goldman Sachs analyst Mark Delaney maintains Aurora Innovation (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AUR#NASDAQ">AUR</a>) with a Neutral and raises the price target from $6 to $7.

Goldman Sachs Maintains Neutral on Aurora Innovation, Raises Price Target to $7

United Parks &amp; Resorts Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/PRKS#NYSE">PRKS</a>) on Monday reported worse-than-expected first-quarter <a href="https://www.benzinga.com/pressreleases/25/05/n45343015/united-parks-resorts-inc-reports-first-quarter-2025-results" target="_blank" rel="noreferrer noopener">2025 results</a>.
The company reported a loss per share of 29 cents, missing the analyst consensus estimate of 21 cents loss. Quarterly sales stood at $286.9 million (down 3.5% year-over-year), missed the analyst view of $294 million.
Total revenue per capita fell 1.8% to $84.62; admissions dropped 4.2% to $46.04, while in-park spending rose 1.1% to a record $38.58.
Also Read: <a href="https://www.benzinga.com//node/45293256">Disney Stock &#8216;Resilient&#8217; In Uncertain Economy As Raised Guidance Signals Confidence</a>
Attendance declined 1.7% year-over-year to 3.4 million, down by about 59,000 guests from the 2024 quarter.
The company repurchased 100,000 shares for $4.6 million and aided 205 wild animals, bringing its total rescued to over 42,000.
Adjusted EBITDA fell 14.8% year-over-year to $67.4 million, down $11.7 million year-over-year.
United Parks exited the quarter with cash and equivalents worth $75.665 million, lower than $115.893 million a year ago.
Total long-term debt (including current maturities) contracted to $2.259 billion from $2.263 billion in the year-ago period.
United Parks &amp; Resorts Inc. Chief Executive Officer Marc Swanson said, &#8220;We are pleased to report another quarter of strong financial results.&#8221; He noted that first-quarter performance was negatively affected by the timing shift of Easter and Spring Break holidays into the second quarter this year, impacting admissions and in-park spending per capita due to the shift in peak operating days.
Swanson also cited timing-related expenses, adding, &#8220;First-quarter results were also impacted by certain timing related impacts that resulted in over five million dollars more of certain expenses being recorded in the first quarter of 2025 compared to the first quarter of 2024. We are also pleased to report that April 2025 attendance was up 8.1% compared to April 2024.&#8221;
He added that 2025 bookings for Discovery Cove, group bookings, and international ticket sales are all tracking ahead of 2024. &#8220;With approximately 75% of our historical attendance and revenue opportunity still ahead of us as of April 30, 2025, we continue to expect new records in revenue and Adjusted EBITDA in 2025.&#8221;
Price Action: PRKS shares are trading higher by 2.08% to $48.16 at the last check on Monday.
Read Next:
<ul class="wp-block-list">
<li><a href="https://www.benzinga.com//node/45325816">Unfavorable Sports Outcomes Have Negatively Affected DraftKings&#8217; Outlook: Analyst</a></li>
</ul>
Image by Kamira via Shutterstock

Earnings

Equities

Guidance

PRKS

Holiday Timing Impacts United Parks' Q1 Performance

Aurinia Pharmaceuticals Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AUPH#NASDAQ">AUPH</a>) reported first-quarter earnings of 16 cents per share, compared to a loss of 7 cents a year ago. This beat the <a href="https://www.benzinga.com/calendars/earnings" target="_blank" rel="noreferrer noopener">consensus of 10 cents</a>.
The biopharma company reported fourth-quarter sales of $62.47 million, up 24% year over year, almost in line with the&nbsp;<a target="_blank" href="https://www.benzinga.com/pressreleases/25/05/b45342443/aurinia-pharmaceuticals-reports-financial-results-for-the-three-months-ended-march-31-2025" rel="noreferrer noopener">consensus of $61.54 million</a>.
<ul class="wp-block-list">
<li>Sales from the LUPKYNIS drug for lupus nephritis jumped 25% year over year to $60 million.</li>
<li>License, collaboration, and royalty revenue, which includes manufacturing services revenue from Aurinia&#8217;s collaboration partner, Otsuka, was $2.5 million, up 14%.</li>
</ul>
The company reported an operating income of $21.85 million compared to a loss of $13.25 million a year ago.
Aurinia reported a net income of $23.34 million, better than the loss of $10.75 million a year ago.
Aurinia CEO Peter Greenleaf noted that the company&#8217;s commercial organization is focused on educating rheumatologists about the benefits of initiating the drug LUPKYNIS earlier in the treatment paradigm.
Guidance:&nbsp;Aurinia reaffirms <a href="https://www.benzinga.com/general/biotech/25/02/44019996/autoimmune-disease-focused-aurinia-pharmaceuticals-reports-quarterly-profit-revenue-outlook-below-expectations" target="_blank" rel="noreferrer noopener">fiscal 2025 revenue guidance</a> of $250 million-$260 million versus the consensus of $257.87 million.
Price Action: Aurinia stock is up 2.29% at $8.18 at the last check On Monday.
Read Next:
<ul class="wp-block-list">
<li><a href="https://www.benzinga.com/25/05/45352770/nrg-surges-as-q1-crushes-forecasts-and-ls-power-deal-supercharges-long-term-outlook" target="_blank" rel="noreferrer noopener">NRG Energy Surges As Q1 Crushes Forecasts, LS Power Deal Supercharges Long-Term Outlook</a></li>
</ul>

Biotech

Health Care

General

AUPH

Aurinia Pharma Swings Into Profit As Q1 Sales Jumps 24%, Sticks To Guidance

Wells Fargo analyst Steven Cahall maintains Stagwell (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/STGW#NASDAQ">STGW</a>) with a Overweight and lowers the price target from $9 to $8.

Comments

Sidus Space

Sidus Space (SIDU) Opciones

No option chain data available. Please try again later

Noticias

SOCIO/CONTRIBUIDOR

BENZINGA GLOBAL